AusPAR: Golimumab (rmc)
Australian Public Assessment Report
Device/Product Name
Simponi
Active ingredients
Golimumab (rmc)
AusPAR Date
Published
Sponsor
Submission Number
PM-2015-01879-1-3
Submission Type
Extension of indications
Decision
Approved